Ann: Appendix 4C and Quarterly Activities Report, page-3

A pretty good result and kudos to management for using revenue not their balance sheet to get through the COVID19 period. Growth at 30% is a fair clip with what sounds like a good pipeline of work still coming through. Thanks for the link Sageboy I look forward to more detail in time on the R&D margin expansion in the works and any disruptive technology they can bring to market. The talk of M&A gets me nervous during these times but CEO has been pretty disciplined so far and he has plenty of skin in the company so hopefully this continues and we can reel in a bargain.